Lori Houle
Corporate Officer/Principal bei NEUMORA THERAPEUTICS, INC.
Profil
Lori Houle is currently the Chief Quality Officer at Neumora Therapeutics, Inc. She previously worked as the Head-Quality at Dermira, Inc. from 2014 to 2017 and as the Vice President-Global Quality at Vir Biotechnology, Inc. from 2017 to 2021.
Ms. Houle holds an MBA from DeVry University and an undergraduate degree from the University of Wisconsin.
Aktive Positionen von Lori Houle
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.04.2021 |
Ehemalige bekannte Positionen von Lori Houle
| Unternehmen | Position | Ende |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.04.2021 |
| DERMIRA, INC. | Corporate Officer/Principal | 01.10.2017 |
Ausbildung von Lori Houle
| University of Wisconsin | Undergraduate Degree |
| DeVry University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
